Universe Pharmaceuticals/$UPC
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Universe Pharmaceuticals
Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.
Ticker
$UPC
Sector
Primary listing
Industry
Pharmaceuticals
Headquarters
Employees
225
ISIN
KYG9442G1385
Website
UPC Metrics
BasicAdvanced
$1.4M
-
-$626.96
1.51
-
Price and volume
Market cap
$1.4M
Beta
1.51
52-week high
$7.50
52-week low
$2.51
Average daily volume
67K
Financial strength
Current ratio
2.542
Quick ratio
2.366
Long term debt to equity
4.697
Total debt to equity
17.569
Interest coverage (TTM)
-26.34%
Profitability
EBITDA (TTM)
-7.534
Gross margin (TTM)
26.37%
Net profit margin (TTM)
-37.90%
Operating margin (TTM)
-34.83%
Effective tax rate (TTM)
-7.47%
Revenue per employee (TTM)
$100,000
Management effectiveness
Return on assets (TTM)
-9.14%
Return on equity (TTM)
-23.76%
Valuation
Price to revenue (TTM)
0.002
Price to free cash flow (TTM)
-0.005
Free cash flow yield (TTM)
-19,455.25%
Free cash flow per share (TTM)
-70,903.53%
Growth
Revenue change (TTM)
-28.74%
3-year revenue growth (CAGR)
-21.71%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Universe Pharmaceuticals stock?
Universe Pharmaceuticals (UPC) has a market cap of $1.4M as of June 30, 2025.
What is the P/E ratio for Universe Pharmaceuticals stock?
The price to earnings (P/E) ratio for Universe Pharmaceuticals (UPC) stock is 0 as of June 30, 2025.
Does Universe Pharmaceuticals stock pay dividends?
No, Universe Pharmaceuticals (UPC) stock does not pay dividends to its shareholders as of June 30, 2025.
When is the next Universe Pharmaceuticals dividend payment date?
Universe Pharmaceuticals (UPC) stock does not pay dividends to its shareholders.
What is the beta indicator for Universe Pharmaceuticals?
Universe Pharmaceuticals (UPC) has a beta rating of 1.51. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.